These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33777481)

  • 1. Effects of Ranolazine and its Combination with Amiodarone on Rapid Pacing-induced Reentrant Atrial Tachycardia in Rabbits.
    Aidonidis I; Simopoulos V; Dipla K; Hatziefthimiou A; Stamatiou R; Skoularigis I; Molyvdas PA
    J Innov Card Rhythm Manag; 2021 Mar; 12(3):4421-4427. PubMed ID: 33777481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model.
    Aidonidis I; Simopoulos V; Stravela S; Dipla K; Stamatiou R; Hatziefthimiou A; Molyvdas PA
    J Interv Card Electrophysiol; 2021 Oct; 62(1):153-159. PubMed ID: 32996039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
    Aidonidis I; Doulas K; Hatziefthimiou A; Tagarakis G; Simopoulos V; Rizos I; Tsilimingas N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):94-101. PubMed ID: 22872232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone plus Ranolazine for Conversion of Post-Cardiac Surgery Atrial Fibrillation: Enhanced Effectiveness in Reduced Versus Preserved Ejection Fraction Patients.
    Simopoulos V; Hevas A; Hatziefthimiou A; Dipla K; Skoularigis I; Tsilimingas N; Aidonidis I
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):559-565. PubMed ID: 30255400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy.
    Tsanaxidis N; Aidonidis I; Hatziefthimiou A; Daskalopoulou SS; Giamouzis G; Triposkiadis F; Skoularigis I
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):372-378. PubMed ID: 28182279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
    Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
    Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
    Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
    Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
    Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.
    Frommeyer G; Schmidt M; Clauß C; Kaese S; Stypmann J; Pott C; Eckardt L; Milberg P
    Eur J Heart Fail; 2012 Dec; 14(12):1322-31. PubMed ID: 23099358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.
    Ellermann C; Kohnke A; Dechering DG; Kochhäuser S; Reinke F; Fehr M; Eckardt L; Frommeyer G
    Pharmacology; 2018; 102(3-4):138-141. PubMed ID: 29982246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
    Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model.
    Frommeyer G; Mittelstedt A; Wolfes J; Ellermann C; Kochhäuser S; Leitz P; Dechering DG; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1155-1161. PubMed ID: 28780600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
    Feld GK; Cha Y
    J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial electrical remodeling by rapid pacing in the isolated rabbit heart: effects of Ca++ and K+ channel blockade.
    Wood MA; Caponi D; Sykes AM; Wenger EJ
    J Interv Card Electrophysiol; 1998 Mar; 2(1):15-23. PubMed ID: 9869992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
    Frommeyer G; Sterneberg M; Dechering DG; Kaese S; Bögeholz N; Pott C; Fehr M; Bogossian H; Milberg P; Eckardt L
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation.
    Wolfes J; Ellermann C; Broer N; Rath B; Willy K; Leitz PR; Lange PS; Eckardt L; Frommeyer G
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33092020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.